Invitation to Alligator Bioscience's Earnings Call on 26 August 2026

LUND, SE / ACCESS Newswire / August 20, 2026 / Alligator Bioscience (STO:ATORX), a biotechnology company whose principal asset is a financial interest in the HER2-targeting antibody programme HLX22, will publish its interim report for April - June …